Literature DB >> 30550793

Evolutionary Pressure against MHC Class II Binding Cancer Mutations.

Rachel Marty Pyke, Wesley Kurt Thompson, Rany M Salem, Joan Font-Burgada, Maurizio Zanetti, Hannah Carter.   

Abstract

Year:  2018        PMID： 30550793     DOI： 10.1016/j.cell.2018.11.050

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  11 in total

Review 1.  Germline Variants Impact Somatic Events during Tumorigenesis.

Authors:  Johnny R Ramroop; Madelyn M Gerber; Amanda Ewart Toland
Journal:  Trends Genet       Date:  2019-05-22       Impact factor: 11.639

2.  Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.

Authors:  Joshua R Veatch; Brenda L Jesernig; Julia Kargl; Matthew Fitzgibbon; Sylvia M Lee; Christina Baik; Renato Martins; A McGarry Houghton; Stanley R Riddell
Journal:  Cancer Immunol Res       Date:  2019-05-01       Impact factor: 11.151

3.  Neoantigen Presentation and IFNγ Signaling on the Same Tumor-associated Macrophage are Necessary for CD4 T Cell-mediated Antitumor Activity in Mice.

Authors:  Ainhoa Perez-Diez; Xiangdong Liu; Polly Matzinger
Journal:  Cancer Res Commun       Date:  2022-05-09

Review 4.  The Functional Hallmarks of Cancer Predisposition Genes.

Authors:  Alexandra Capellini; Matthew Williams; Kenan Onel; Kuan-Lin Huang
Journal:  Cancer Manag Res       Date:  2021-06-01       Impact factor: 3.989

5.  Quantifying immune-based counterselection of somatic mutations.

Authors:  Fan Yang; Dae-Kyum Kim; Hidewaki Nakagawa; Shuto Hayashi; Seiya Imoto; Lincoln Stein; Frederick P Roth
Journal:  PLoS Genet       Date:  2019-07-25       Impact factor: 5.917

Review 6.  Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy.

Authors:  Miren Zuazo; Hugo Arasanz; Ana Bocanegra; Gonzalo Fernandez; Luisa Chocarro; Ruth Vera; Grazyna Kochan; David Escors
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561

7.  Association between variant alleles of major histocompatibility complex class II regulatory genes and nasopharyngeal carcinoma susceptibility.

Authors:  Ping Zhou; Sha Liu; Nan-Nan Ji; Shuang Zhang; Peng Wang; Bing Lin; Ping Yang; Xian-Tao Lin; Yi-Zheng Cai; Zi-Ming Wang; Han Zhou; Shi-Yao Sun; Xin-Bao Hao
Journal:  Eur J Cancer Prev       Date:  2020-11       Impact factor: 2.164

Review 8.  Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development.

Authors:  Jie Liang; Xiao Zhao
Journal:  Cancer Biol Med       Date:  2021-05-12       Impact factor: 4.248

9.  A machine learning algorithm with subclonal sensitivity reveals widespread pan-cancer human leukocyte antigen loss of heterozygosity.

Authors:  Rachel Marty Pyke; Dattatreya Mellacheruvu; Steven Dea; Charles W Abbott; Lee McDaniel; Devayani P Bhave; Simo V Zhang; Eric Levy; Gabor Bartha; John West; Michael P Snyder; Richard O Chen; Sean Michael Boyle
Journal:  Nat Commun       Date:  2022-04-12       Impact factor: 14.919

Review 10.  The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.

Authors:  Denis L Jardim; Aaron Goodman; Debora de Melo Gagliato; Razelle Kurzrock
Journal:  Cancer Cell       Date:  2020-10-29       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.